Aba Ankara

Producing immunodiagnostic tests for Hepatitis B, Hepatitis C, HIV, and TORCH in English.

General Information
Company Name
Aba Ankara
Founded Year
2010
Location (Offices)
Turkey
Founders / Decision Makers
Number of Employees
-
Industries
Biotechnology, Deep Tech, Life Sciences
Funding Stage
-
Social Media

Aba Ankara - Company Profile

Aba Ankara is a Turkish startup in the biotechnology, Deep Tech, and Life Sciences industries. Established in 2010, the company specializes in producing immunodiagnostic tests for Hepatitis B, Hepatitis C, HIV, and TORCH. Aba Ankara's slogan highlights its focus on producing these critical tests in the English language. As of now, there is no public information available about the latest investment and the participating investors. With its focus on essential medical diagnostics and its presence in a diverse range of industries, Aba Ankara presents an intriguing opportunity for potential investors in the healthcare and biotechnology sectors.

Taxonomy: Immunodiagnostic tests, Manufacturing industry, Hepatitis B, Hepatitis C, HIV, TORCH, Medical diagnostics, Healthcare manufacturing, Infectious diseases, Medical technology

Funding Rounds & Investors of Aba Ankara (0)

View All

There is no investment information

Latest News of Aba Ankara

View All

No recent news or press coverage available for Aba Ankara.

Similar Companies to Aba Ankara

View All
ASHM - Similar company to Aba Ankara
ASHM Building a sustainable HIV, Viral Hepatitis and Sexual Health workforce.
NASTAD - Similar company to Aba Ankara
NASTAD NASTAD's vision is a world committed to ending HIV/AIDS, viral hepatitis, and intersecting epidemics.
Replicor Inc. - Similar company to Aba Ankara
Replicor Inc. 292 million people have chronic hepatitis B. We're developing the cure.
Biolex Therapeutics - Similar company to Aba Ankara
Biolex Therapeutics Harnessing aquatic innovation for potent protein therapeutics and advanced Hepatitis C treatments.
Anadys Pharmaceuticals - Similar company to Aba Ankara
Anadys Pharmaceuticals Pioneering the future of hepatitis C treatment with innovative antiviral therapies